A. Al-rawaq, N. Neamah, and A. Alhamza, “Asprosin as a novel biomarker for predicting diabetes mellitus risk in humans”, Trop. J. Pharm Res, vol. 25, no. 2, pp. 155–160, Mar. 2026.